Select Publications
Conference Abstracts
2023, 'The risk of congenital malformations in infants exposed in the first trimester to smoking cessation pharmacotherapies: A multi-national cohort study', Sydney, presented at Centre of Research Excellence in Medicines Intelligence Symposium 2023, Sydney, 02 November 2023 - 03 November 2023
,2023, 'Utilisation of smoking cessation pharmacotherapies during pregnancy: a multi-national population-based study', Adelaide, South Australia, presented at APSAD Australasian Professional Society on Alcohol and other Drugs 2023, Adelaide, South Australia, 27 October 2023 - 30 October 2023
,2023, 'The safety of quit smoking medications during pregnancy: the risk of congenital malformations in infants', UNSW Sydney, presented at National Drug and Alcohol Research Centre Symposium 2023, UNSW Sydney, 26 October 2023
,2023, 'First trimester exposure to smoking cessation pharmacotherapies and the risk of major congenital malformations: A multi-national cohort study', Halifax, Nova Scotia, Canada, presented at 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Halifax, Nova Scotia, Canada, 23 August 2023
,2022, 'Maternal diabetes and attention-deficit/hyperactivity disorder in childhood', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, Vol. 65, pp. S68 - S69, presented at 58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SWEDEN, Stockholm, 19 September 2022 - 23 September 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000841795900132&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Patterns of ADHD medicine use: A population-based study among Australian children and adults (2013-2020)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 71 - 71, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084400136&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Prenatal exposure to antiseizure medication and intrauterine growth restriction in offspring of women with epilepsy', in EPILEPSIA, WILEY, ELECTR NETWORK, Vol. 62, pp. 6 - 7, presented at 34th International Epilepsy Congress, ELECTR NETWORK, 28 August 2021 - 01 September 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000714115400012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Prenatal exposure to antiseizure medication duotherapy and risk of neurodevelopmental disorders -SCAN-AED: a Nordic nationwide cohort study', in EPILEPSIA, WILEY, ELECTR NETWORK, Vol. 62, pp. 24 - 25, presented at 34th International Epilepsy Congress, ELECTR NETWORK, 28 August 2021 - 01 September 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000714115400036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Prenatal exposure to high dose folic acid and risk of childhood cancer: A Nordic Register-Based Cohort Study', in EPILEPSIA, WILEY, ELECTR NETWORK, Vol. 62, pp. 360 - 361, presented at 34th International Epilepsy Congress, ELECTR NETWORK, 28 August 2021 - 01 September 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000714115400688&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Children's relative age and medicine treatment for attention-deficit/hyperactivity disorder (ADHD) across Australian jurisdictions with different school enrolment policies', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 166 - 167, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300335&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Evaluating the impact of new prescribing restrictions for publicy-subsidised proton pump inhibitors in Australia: An interrupted time series analysis', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 219 - 220, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300446&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Metformin versus insulin in early pregnancy and risk of congenital malformations', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 61 - 62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300124&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Opioid utilization among older adults in all Nordic countries 2009-2018', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 285 - 286, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300579&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Prenatal antiseizure medication exposure and risk of autism and intellectual disability. SCAN-AED: A Nordic cohort study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 72 - 73, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'The impact of in-utero antipsychotic drug exposure on congenital malformations: An international cohort study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 74 - 75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Prenatal antiseizure medication exposure and risk of autism and intellectual disability.SCAN-AED: a Nordic cohort study', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, Vol. 28, pp. 105 - 106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000663065900171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Prenatal exposure to antiseizure medication and the full spectrum of diagnosed psychiatric disorders: A SCANA-ED study', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, Vol. 28, pp. 106 - 107, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000663065900172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Maternal and Neonatal Outcomes Associated with Psychostimulant Use in Pregnancy', in International Journal of Population Data Science, Swansea University, Vol. 5, http://dx.doi.org/10.23889/ijpds.v5i5.1579
,2020, 'Antipsychotic use during pregnancy and neurodevelopmental outcomes in children: A nordic population register-based study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 557 - 558, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577640501566&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Risks of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide (HCTZ)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 37 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577640500077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Comparative Safety of Antiepileptic Drugs and Risk of Major Congenital Malformations', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 13 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785600019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Non-aspirin non-steroidal anti-inflammatory drug use in the Nordic countries 2000-2016 from a cardiovascular risk perspective: A drug-utilization study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 144 - 145, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785601050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Proton pump inhibitor (PPI) use in Australia: Evaluating national quality use of medicines initiatives', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 519 - 519, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785604010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Use of proton pump inhibitors and mortality among Icelandic prostate cancer patients', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 520 - 520, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785604012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Antipsychotic drug use in pregnancy: A multinational database study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 27, pp. 235 - 235
,2018, 'Use of antiepileptic drugs in pregnancy: A multinational register-based study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 27, pp. 234 - 235, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000441893802058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Reports
2017, Post-market Review - Pulmonary Arterial Hypertension Medicines
,Preprints
2023, Childhood maltreatment and subsequent risk of hospitalization or death due to COVID-19: a cohort study in the UK Biobank, , http://dx.doi.org/10.1101/2023.09.12.23295354
,2023, Fetal Growth Restriction After Prenatal Exposure to Antiseizure Medication, , http://dx.doi.org/10.2139/ssrn.4549178
,2021, Changes in antidepressant use in Australia: A nationwide analysis prior to and during the COVID-19 pandemic (2015-2021), , http://dx.doi.org/10.1101/2021.11.24.21266837
,2021, Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia, , http://dx.doi.org/10.1101/2021.09.26.21264150
,